Broad detection of alterations predicted to confer lack of benefit from EGFR antibodies or sensitivity to targeted therapy in advanced colorectal cancer

Andrew Rankin, Samuel J. Klempner, Rachel Erlich, James X. Sun, Axel Grothey, Marwan Fakih, Thomas J. George, Jeeyun Lee, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Alexa B. Schrock

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Broad detection of alterations predicted to confer lack of benefit from EGFR antibodies or sensitivity to targeted therapy in advanced colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences